Neurodegeneration Software
-
by Cortechs.aibased in USA
NeuroQuant Dementia Age Related Atrophy Report - For the assessment of dementia, Alzheimer’s disease and other neurodegenerative conditions. The NeuroQuant Dementia report helps physicians in the assessment of patients with cognitive impairment and memory loss, providing objective quantitative measurements of ...
-
by Vuno Inc.based in SOUTH KOREA
VUNO Med-DeepBrain serves as a supporting tool for diagnosis of neurodegenerative diseases to execute brain parcellation in brain MRI and provide quantitative data on brain ...
-
by Cortechs.aibased in USA
For the assessment of multiple sclerosis and other neurodegenerative conditions. Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. NeuroQuant MS combines T2 FLAIR with 3D T1 MR images to enhance your ability to identify and monitor the number and progression of brain lesions. Accurately ...
-
by Cortechs.aibased in USA
For the assessment of brain volumes for multiple sclerosis and age-associated neurodegenerative conditions. The NeuroQuant Multi-Structure Atrophy Report presents volumetric information for whole brain, superior lateral ventricles, thalamus, cortical gray matter, cerebral white matter, cerebral white matter hypointensities, 3d ventricle, hippocampus, and inferior lateral ventricles. The MSA ...
-
by Cortechs.aibased in USA
For the assessment of traumatic brain injury and other neurodegenerative conditions. The NeuroQuant TBA Report provides physicians a quick reference and in-depth look on regional and global brain structure volumes, which could occur as a result of a brain injury or neurodegenerative disease, by providing volume measurements of 47 brain structures for both the right and left hemisphere, total ...
-
based in USA
Most rare and inherited diseases have a neurological component, likely because more than 80% of human genes are expressed in the brain.1 Neurological disorders are multifactorial and heterogeneous, meaning that their genetic basis is often poorly understood. Indeed, only 30-50% of neurological disorders have a molecular genetic diagnosis.2 ...
-
by Qynapsebased in FRANCE
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier precision on the frontlines of CNS disease. QyScore is intended for automatic labeling, visualization and volumetric quantification of segmentable brain ...
-
based in USA
Beacon provides a scalable EEG analytics platform aimed at accelerating and de-risking therapeutics in neurology, psychiatry, and sleep medicine. Powered by a combination of unique data assets and machine learning algorithms, our platform identifies and standardizes neurobiomarkers to increase the probability of success at each stage of drug ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you